Nov 15, 2016 12:30 pm UTC| Business
ROMAINVILLE, France, Nov. 15, 2016 -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat diseases of aging, announced today that four posters on...
Alcobra Announces Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 15, 2016 12:30 pm UTC| Business
Conference Call Webcast November 15th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, Nov. 15, 2016 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of...
Nov 15, 2016 12:30 pm UTC| Business
BELLEVUE, Wash., Nov. 15, 2016 -- J. Braxton Carter, Executive Vice President Chief Financial Officer, Neville Ray, Executive Vice President Chief Technology Officer and Peter Ewens, Executive Vice President,...
Nov 15, 2016 12:05 pm UTC| Business
~ Company Structure Simplified; Manufacturing to be Consolidated into Lexington, MA ~ Preparation Underway for Late-Stage Development in Hemophilia B ~ Cost Savings Expected to Extend Cash Resources into 2019 ~ Company...
Matinas BioPharma Reports 2016 Third Quarter Financial Results and Provides Corporate Update
Nov 15, 2016 12:05 pm UTC| Business
– Company to commence initial study in the Phase 1 program for MAT2501 and second Phase 2 study for MAT2203 in Q4 2016 – – On track to report Phase 2 topline data for MAT2203 in the first half of 2017 – BEDMINSTER,...
Nov 15, 2016 12:00 pm UTC| Business
European Patent Office Dismisses Arguments by Regeneron Favorable Rulings Further Strengthen IP Estate in Europe and Japan through 2029 UTRECHT, The Netherlands, Nov. 15, 2016 -- Merus N.V. (NASDAQ:MRUS), a...
Pluristem Reports First Quarter Fiscal 2017 Corporate and Financial Highlights
Nov 15, 2016 12:00 pm UTC| Business
$30 million equity investment term sheet signed with large Chinese investment fund active in the healthcare industrySignificant advancement towards initiation of pivotal Phase III trials U.S. FDA provided positive feedback...